The ticker symbol EQ is assigned to Equillium, Inc., a clinical-stage biotechnology enterprise listed on the NASDAQ exchange that focuses on developing novel therapeutics for severe autoimmune and inflammatory disorders. Additionally, investors in Canadian markets frequently reference EQB Inc. (TSX: EQB), the financial services holding company that operates EQ Bank.